Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 15, 2021 - Issue
Submit an article Journal homepage
106
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment

Xi-Qian Zhang1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Li-Jia Zhang1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Xiu-Lan Zhu1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Hong Xu1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Yan-Qun Luo1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Li Yao1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Qian-Wen Huang1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Ying-Qi Nong1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
,
Wen-Juan Liu1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaView further author information
&
Feng-Hua Liu1 Reproductive Medical Center, Guangdong Women and Children Hospital, Guangzhou, 511442, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 3573-3580 | Published online: 16 Aug 2021

References

  • WuJ, DongX, LiuK, et al. Association of semenogelin (SEMG) gene variants in idiopathic male infertility in Chinese-Han population. J Toxicol Environ Health A. 2019;82(16):928–934. doi:10.1080/15287394.2019.166930431535590
  • WangLJ. Current status of cognitive behaviors and stress in patients with infertility based on Maslow’s hierarchy theory and the influencing factors. Chin J Health Psychol. 2019;27:64–67.
  • NardoLG, BoschE, LambalkCB, GelbayaTA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS policy and practice committee. Hum Fertil (Camb). 2013;16(3):144–150. doi:10.3109/14647273.2013.79538523705667
  • RodgersRJ, ReidGD, KochJ, et al. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Hum Reprod. 2017;32(5):1033–1045. doi:10.1093/humrep/dex02728333356
  • van WelyM, WestergaardLG, BossuytPM, van der VeenF. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertil Steril. 2003;80(5):1086–1093. doi:10.1016/S0015-0282(03)02187-314607553
  • QiaoJ, MaCH, LiuJY, et al. A consensus of poor ovarian response. Chin J Reprod Contracept. 2015;35:211–223.
  • WinstelR, WielandJ, GertzB, MuellerA, AllgaierH. Manufacturing of recombinant human follicle-stimulating hormone ovaleap® (X M 1 7), comparability with G onal-f®, and performance/consistency. Drugs R D. 2017;17(2):305–312. doi:10.1007/s40268-017-0182-z28386738
  • MoonSY, ChoiYS, KuSY, et al. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology. J Obstet Gynaecol Res. 2007;33(3):305–315. doi:10.1111/j.1447-0756.2007.00529.x17578360
  • AboulgharMA, MansourRT, SerourGI, RamzyAM. Successful treatment of infertile women with hypothalamic primary and secondary protracted amenorrhoea using gonadotrophin releasing hormone analogue and human menopausal gonadotrophin. Human Reprod. 1990;5(5):557–560. doi:10.1093/oxfordjournals.humrep.a137142
  • YangTS, WangBC, ChangSP, NgHT. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization. Zhonghua Yi Xue Za Zhi (Taipei). 1995;55:452–456.7634183
  • GrøndahlML, BorupR, LeeYB, MyrhøjV, MeinertzH, SørensenS. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin. Fertil Steril. 2009;91(5):1820–1830. doi:10.1016/j.fertnstert.2008.02.13718439596
  • CaoM, WangJL, WuYZ, et al. Advances in the development of recombinant human follicle-stimulating hormone. Pharm Biotechnol. 2014;21:86–90.
  • HeYK, XuW, LuWY, et al. Clinical observation of domestic rhFSH and Gonal-f on ovulation promotion in patients with ovulation disorders. J Hainan Med Coll. 2010;16:417–420.
  • LiuXZ, ChenYW, GuoSS. A comparative study on the clinical application of two ovulation-promoting drugs. Contemp Med. 2020;26:26–27.
  • ŠalamunV, VerdenikI, LaganàAS, Vrtačnik-BokalE. Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis. Arch Gynecol Obstet. 2018;297(3):613–621. doi:10.1007/s00404-017-4633-029274003
  • FacchinettiF, EspinolaMSB, DewaillyD, et al. Expert group on inositols in preclinical and clinical research. Breakthroughs in the use of inositols for assisted reproductive treatment (ART). Trends Endocrinol Metab. 2020;31(8):570–579. doi:10.1016/j.tem.2020.04.00332418772
  • Di PaolaR, GarzonS, GiulianiS, et al. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman’s age and markers of ovarian reserve. Arch Gynecol Obstet. 2018;298(5):1029–1035. doi:10.1007/s00404-018-4906-230242498
  • PelusoC, OliveiraR, LaportaGZ, et al. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis. Gynecol Endocrinol. 2021;37(4):358–366. doi:10.1080/09513590.2020.178650932613875

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.